A citation-based method for searching scientific literature

Meng-Ling Chen, Chih-Chun Lin, Liana S Rosenthal, Puneet Opal, Sheng-Han Kuo. J Neurol Sci 2021
Times Cited: 3







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Spinocerebellar ataxia.
Thomas Klockgether, Caterina Mariotti, Henry L Paulson. Nat Rev Dis Primers 2019
185
100

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Carlo Wilke, Eva Haas, Kathrin Reetz, Jennifer Faber, Hector Garcia-Moreno, Magda M Santana, Bart van de Warrenburg, Holger Hengel, Manuela Lima, Alessandro Filla,[...]. EMBO Mol Med 2020
29
100

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
66

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Theresa A Zesiewicz, George Wilmot, Sheng-Han Kuo, Susan Perlman, Patricia E Greenstein, Sarah H Ying, Tetsuo Ashizawa, S H Subramony, Jeremy D Schmahmann, K P Figueroa,[...]. Neurology 2018
54
66

Targeting potassium channels to treat cerebellar ataxia.
David D Bushart, Ravi Chopra, Vikrant Singh, Geoffrey G Murphy, Heike Wulff, Vikram G Shakkottai. Ann Clin Transl Neurol 2018
35
66

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
108
66


White matter damage is related to ataxia severity in SCA3.
J-S Kang, J C Klein, S Baudrexel, R Deichmann, D Nolte, R Hilker. J Neurol 2014
35
66

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
304
66

Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients.
Alex Tiburtino Meira, Walter Oleschko Arruda, Sergio Eiji Ono, Gustavo Leite Franklin, Arnolfo de Carvalho Neto, Salmo Raskin, Tetsuo Ashizawa, Carlos Henrique F Camargo, Hélio A G Teive. Parkinsonism Relat Disord 2020
5
66

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
170
66

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
92
66

Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Isaac M Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel. Neuroimage Clin 2018
44
66

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
116
66


The spinocerebellar ataxias.
Henry L Paulson. J Neuroophthalmol 2009
125
66

Spinocerebellar ataxia: an update.
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden. J Neurol 2019
75
66

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
106
66

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
Rachel P Guimarães, Anelyssa D'Abreu, Clarissa L Yasuda, Marcondes C França, Beatriz H B Silva, Fabio A M Cappabianco, Felipe P G Bergo, Iscia T Lopes-Cendes, Fernando Cendes. Mov Disord 2013
56
66

Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders.
Andrew E Mulberg, Christina Bucci-Rechtweg, Joseph Giuliano, David Jacoby, Franklin K Johnson, Qing Liu, Deborah Marsden, Scott McGoohan, Robert Nelson, Nita Patel,[...]. Orphanet J Rare Dis 2019
22
33

Cerebrospinal Fluid Biomarkers for Huntington's Disease.
Lauren M Byrne, Edward J Wild. J Huntingtons Dis 2016
36
33

Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
Anelyssa D'Abreu, Marcondes C França, Clarissa L Yasuda, Bruno A G Campos, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2012
58
33

Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1.
Yuan-Shih Hu, Jeehaeh Do, Chandrakanth Reddy Edamakanti, Ameet R Kini, Marco Martina, Samuel I Stupp, Puneet Opal. Brain 2019
9
33

Advances in oligonucleotide drug delivery.
Thomas C Roberts, Robert Langer, Matthew J A Wood. Nat Rev Drug Discov 2020
394
33



Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.
Andrea Varrone, Elena Salvatore, Giuseppe De Michele, Paolo Barone, Valeria Sansone, Maria Teresa Pellecchia, Imma Castaldo, Giovanni Coppola, Arturo Brunetti, Marco Salvatore,[...]. Ann Neurol 2004
48
33

Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
Gerson da Silva Carvalho, Jonas Alex Morales Saute, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Gheno, Aline Russo, Thais Lampert Monte,[...]. Cerebellum 2016
19
33

Polyglutamine Repeats in Neurodegenerative Diseases.
Andrew P Lieberman, Vikram G Shakkottai, Roger L Albin. Annu Rev Pathol 2019
102
33

The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3.
Shi-Rui Gan, Karla P Figueroa, Hao-Ling Xu, Susan Perlman, George Wilmot, Christopher M Gomez, Jeremy Schmahmann, Henry Paulson, Vikram G Shakkottai, Sarah H Ying,[...]. Parkinsonism Relat Disord 2020
8
33


Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
Gaurav Goel, Pramod Kumar Pal, Shivashankar Ravishankar, Ganesan Venkatasubramanian, Peruvumba N Jayakumar, Nithin Krishna, Meera Purushottam, Jitender Saini, Mohammed Faruq, Mitali Mukherji,[...]. Parkinsonism Relat Disord 2011
45
33

Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.
Takashi Hosaka, Takenari Yamashita, Akira Tamaoka, Shin Kwak. Int J Mol Sci 2019
23
33

RNA toxicity in non-coding repeat expansion disorders.
Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch. EMBO J 2020
83
33

Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Jie Zhou, Lifang Lei, Yuting Shi, Junling Wang, Hong Jiang, Lu Shen, Beisha Tang. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011
7
33

The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families.
M Lieto, V Riso, D Galatolo, G De Michele, S Rossi, M Barghigiani, S Cocozza, G Pontillo, R Trovato, F Saccà,[...]. Eur J Neurol 2020
32
33


Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
Jiing-Feng Lirng, Po-Shan Wang, Hung-Chieh Chen, Bing-Wen Soong, Wan Yuo Guo, Hsiu-Mei Wu, Cheng-Yen Chang. PLoS One 2012
30
33


MicroRNA profiling in the serums of SCA3/MJD patients.
Yuting Shi, Fengzhen Huang, Beisha Tang, Jiada Li, Junling Wang, Lu Shen, Kun Xia, Hong Jiang. Int J Neurosci 2014
32
33


Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
Po-Shan Wang, Hung-Chieh Chen, Hsiu-Mei Wu, Jiing-Feng Lirng, Yu-Te Wu, Bing-Wen Soong. PLoS One 2012
19
33

Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease.
Amber L Southwell, Holly B Kordasiewicz, Douglas Langbehn, Niels H Skotte, Matthew P Parsons, Erika B Villanueva, Nicholas S Caron, Michael E Østergaard, Lisa M Anderson, Yuanyun Xie,[...]. Sci Transl Med 2018
65
33

Dentatorubral-pallidoluysian Atrophy: An Update.
Liam S Carroll, Thomas H Massey, Mark Wardle, Kathryn J Peall. Tremor Other Hyperkinet Mov (N Y) 2018
7
33

Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.
Gülin Oz, Isabelle Iltis, Diane Hutter, William Thomas, Khalaf O Bushara, Christopher M Gomez. Cerebellum 2011
47
33

Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Ullrich Wüllner, Michael Reimold, Michael Abele, Katrin Bürk, Martina Minnerop, Bernd-Michael Dohmen, Hans-Juergen Machulla, Roland Bares, Thomas Klockgether. Arch Neurol 2005
70
33

Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3.
Jonas Alex Morales Saute, Andrew Chaves Feitosa da Silva, Alexandre Pastoris Muller, Gisele Hansel, Alexandre Silva de Mello, Fábio Maeda, Leonardo Vedolin, Maria Luiza Saraiva-Pereira, Diogo Onofre Souza, Javier Arpa,[...]. Mov Disord 2011
22
33

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
301
33

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Isaac M Adanyeguh, Pierre-Gilles Henry, Tra M Nguyen, Daisy Rinaldi, Celine Jauffret, Romain Valabregue, Uzay E Emir, Dinesh K Deelchand, Alexis Brice, Lynn E Eberly,[...]. Mov Disord 2015
46
33

Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.
Katrin Bürk, Stefanie R Schulz, Jörg B Schulz. J Neurochem 2013
40
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.